Showing results (301-310 of 326) with videos related to
Sort By:
Pageof 33
Chemmedchem|February 16, 2022
Design, Synthesis and X-Ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-Furofuran Derivatives as P2 LigandsArun K Ghosh, Satish Kovela, Ashish Sharma, et al.Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.Life (Basel, Switzerland)|June 24, 2022
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)Noriko Tomita, Sho Saito, Junko Terada-Hirashima, et al.Viruses|October 28, 2023
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 SubtypesMaria E Cilento, Xin Wen, Aaron B Reeve, et al.Cell Reports Methods|April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitroKouki Matsuda, Saiful Islam, Toru Takada, et al.Frontiers in Immunology|December 25, 2012
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneCarl K Edwards, Julie S Green, Hans-Dieter Volk, et al.Scientific Reports|November 25, 2021
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individualsKenji Maeda, Masayuki Amano, Yukari Uemura, et al.Medrxiv : the Preprint Server for Health Sciences|August 10, 2021
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated IndividualsKenji Maeda, Masayuki Amano, Yukari Uemura, et al.GHM Open|March 27, 2025
Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: A single-center, open-label, single-arm, interventional study in JapanSatoshi Kutsuna, Sho Saito, Yuki Takamatsu, et al.Cancer Science|September 25, 2024
Decreased PU.1 expression in mature B cells induces lymphomagenesisShinya Endo, Nao Nishimura, Kosuke Toyoda, et al.Pageof 33